Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-10
1993-06-15
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546189, C07D21132, A61K 31445
Patent
active
052198677
ABSTRACT:
The present invention relates to substantially pure stereoisomers of a compound of the formula: ##STR1## wherein n.sub.1 and n.sub.2 are the same or different and are 1 or 2; X is alkyl (C.sub.1 -C.sub.10), aryl (C.sub.6 -C.sub.10) or aralkyl (C.sub.7 -C.sub.12); and wherein R, R.sub.1, R.sub.2 and R.sub.3 are the same or different and are chosen from H, alkyl (C.sub.1 -C.sub.10), aryl (C.sub.6 -C.sub.10), aralkyl (C.sub.7 -C.sub.12), or a heterocyclic group, and addition salts thereof with pharmaceutically acceptable acids. The invention also relates to a method for the inhibition of blood platelet aggregation in a blood supply comprising administering to said blood supply a blood platelet aggregation inhibiting amount of the compounds of the present invention.
REFERENCES:
patent: 4634709 (1987-01-01), Lasslo et al.
patent: 4657917 (1987-04-01), Lasslo et al.
Gollamudi, et al., Chirality, 1991, 3, 480-483.
Feng Zixia
Gollamudi Ramachander
Cintins Marianne M.
Hydorn Michael B.
Research Corporation Technologies Inc.
LandOfFree
Platelet aggregation inhibitory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet aggregation inhibitory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet aggregation inhibitory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1042939